These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15404227)

  • 1. The virulence and immunogenicity of strains derived from Salmonella typhosa 58 (Panama carrier).
    BATSON HC; LANDY M; BROWN M
    J Exp Med; 1950 Feb; 91(2):231-43. PubMed ID: 15404227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of typhoid antigens in protection and pathogenicity for mice.
    Diena BB; Baron LS; Johnson EM; Wallace R; Ashton FE
    Infect Immun; 1974 Jun; 9(6):1102-4. PubMed ID: 4598256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay of typhoid vaccines with Salmonella typhosa-Salmonella typhimurium hybrids.
    Diena BB; Johnson EM; Baron LS; Wallace R; Greenberg L
    Infect Immun; 1973 Jan; 7(1):5-8. PubMed ID: 4120357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A virulent isolate of Salmonella typhosa 58 (Panama carrier).
    BATSON HC; LANDY M; ABRAMS A
    Public Health Rep (1896); 1949 May; 64(21):671-4. PubMed ID: 18149802
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathogenicity of Salmonella typhimurium administered subcutaneously to mice in mixture with each polynucleotide complex from Salmonella typhimurium, Salmonella typhosa, and Salmonella newport.
    SCHNEIDER MD
    Am J Vet Res; 1951 Oct; 12(45):340-4. PubMed ID: 14878128
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of differences in virulence of strains of Salmonella typhosa; a comparison of methods.
    BATSON HC; LANDY M; BROWN M
    J Exp Med; 1950 Feb; 91(2):219-29. PubMed ID: 15404226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Virulence and immunogenic properties of Salmonella typhi, immunogenic properties of vaccines and Vi-antigen content as determined by hemagglutination reaction].
    ORLOVA TG
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Aug; 29(8):105-10. PubMed ID: 13605076
    [No Abstract]   [Full Text] [Related]  

  • 8. ALTERATIONS IN THE MOUSE VIRULENCE OF SALMONELLA TYPHIMURIUM BY GENETIC RECOMBINATION.
    KRISHNAPILLAI V; BARON LS
    J Bacteriol; 1964 Mar; 87(3):598-605. PubMed ID: 14127576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infectivity and antigenicity of streptomycin-dependent Salmonella typhosa.
    Reitman M
    J Infect Dis; 1967 Feb; 117(1):101-7. PubMed ID: 4165395
    [No Abstract]   [Full Text] [Related]  

  • 10. Immuno-chemical analysis of dissociated forms of typhoid bacilli in connexion with changes in their virulence and immunogenicity.
    PETROVSKAYA VG; KORNEYEVA AM; KUDLAI DG; SOLOV'EVA GK; KHRAMKOVA NI
    Zh Mikrobiol Epidemiol Immunobiol; 1961; 32():1695-703. PubMed ID: 14038328
    [No Abstract]   [Full Text] [Related]  

  • 11. An antigenic basis for virulence in strains of Salmonella typhimurium.
    JENKIN CR
    J Exp Med; 1962 Apr; 115(4):731-43. PubMed ID: 14451585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible synthesis of colanic acid and O-antigen polysaccharides in Salmonella Typhimurium enhances induction of cross-immune responses and provides protection against heterologous Salmonella challenge.
    Li P; Liu Q; Huang C; Zhao X; Roland KL; Kong Q
    Vaccine; 2017 May; 35(21):2862-2869. PubMed ID: 28412074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on immunogenicity and protective efficacy of DnaJ of Salmonella Typhi against lethal infection by Salmonella Typhimurium in mice.
    Sagi SS; Paliwal P; Bansal A; Mishra C; Khan N; Mustoori SR; Ilavazhagan G; Sawhney RC; Banerjee PK
    Vaccine; 2006 Nov; 24(49-50):7135-41. PubMed ID: 16887241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium.
    Colwell DE; Michalek SM; Briles DE; Jirillo E; McGhee JR
    J Immunol; 1984 Aug; 133(2):950-7. PubMed ID: 6203984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of recombinant Salmonellae expressing hybrid hepatitis B virus core particles as candidate oral vaccines.
    Schödel F; Kelly SM; Peterson D; Milich D; Hughes J; Tinge S; Wirtz R; Curtiss R
    Dev Biol Stand; 1994; 82():151-8. PubMed ID: 7958469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody formation in the rat. II. Agglutinin response to soluble flagellin from salmonella typhosa.
    FITCH FW; WINEBRIGHT J
    J Immunol; 1962 Dec; 89():900-5. PubMed ID: 13945336
    [No Abstract]   [Full Text] [Related]  

  • 17. Differences in the carriage and the ability to utilize the serotype associated virulence plasmid in strains of Salmonella enterica serotype Typhimurium investigated by use of a self-transferable virulence plasmid, pOG669.
    Olsen JE; Brown DJ; Thomsen LE; Platt DJ; Chadfield MS
    Microb Pathog; 2004 Jun; 36(6):337-47. PubMed ID: 15120160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of mice and guinea-pigs against Salmonella dublin infection with live and inactivated vaccine.
    Cameron CM; Fuls WJ
    Onderstepoort J Vet Res; 1975 Jun; 42(2):63-9. PubMed ID: 1107926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HETEROLOGOUS IMMUNITY AGAINST S. TYPHI BY VACCINES OF LIVING E. FREUNDII VI STRAINS ASSOCIATED WITH SALMONELLAE OF THE "D" GROUP.
    SCHAEFLER S; MINTZER L; ZILISTEANU E
    Z Immunitats Allergieforsch; 1964 Jun; 126():431-7. PubMed ID: 14248913
    [No Abstract]   [Full Text] [Related]  

  • 20. The virulence and immunogenicity of Salmonella typhosa grown in continuous culture.
    BARON LS; FORMAL SB; SPILMAN W
    J Bacteriol; 1956 Aug; 72(2):168-75. PubMed ID: 13366894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.